Led by Dr. Imperato-McGinley, the CTSC Receives $61.9 Million Grant from NIH (NCATS)

Dr. Julianne Imperato-McGinley

The WDOM congratulates Dr. Julianne Imperato-McGinley on her continued service as Principal Investigator (and Founding Director) of the Clinical and Translational Science Center (CTSC).

Dr. Imperato-McGinley has forged numerous breakthrough advances over the years serving as Principal Investigator of the CTSC at Weill Cornell Medicine, and with a recent $61.9 million award (funded until 2027) from the NIH’s National Center for Advancing Translational Sciences (NCATS) she will continue her seminal work. This award is the largest federal grant ever given to Weill Cornell Medicine and represents 20 years of continuous funding for the CTSC under Dr. Imperato-McGinley’s direction.

Since receiving an award of $49.6 million from the NIH in 2007, Dr. Imperato-McGinley has been advancing translation science with prestigious partner institutions that includes a core network of scientific institutions combining expertise to accelerate innovative discoveries.

Related Links

WCM Newsroom